{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:46:35Z","timestamp":1787013995706,"version":"build-2736575974"},"reference-count":63,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Eosinophilic granulomatosis with polyangiitis (\n                      <jats:styled-content style=\"fixed-case\">EGPA<\/jats:styled-content>\n                      ) is a disease characterized by allergic granulomatosis, necrotizing vasculitis, and peripheral blood eosinophilia. Interleukin (\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      )\u201033, thymic stromal lymphopoietin (\n                      <jats:styled-content style=\"fixed-case\">TSLP<\/jats:styled-content>\n                      ), and type 2 innate lymphoid cells (\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2) are involved in the innate and type 2 immune responses in\n                      <jats:styled-content style=\"fixed-case\">EGPA<\/jats:styled-content>\n                      . However, the relationships among these molecules and the mechanisms underlying the development of\n                      <jats:styled-content style=\"fixed-case\">EGPA<\/jats:styled-content>\n                      remain unknown.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      We investigated the relationships among peripheral blood eosinophil count, serum\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u201033 and\n                      <jats:styled-content style=\"fixed-case\">TSLP<\/jats:styled-content>\n                      concentration, and peripheral blood\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2 count in patients with\n                      <jats:styled-content style=\"fixed-case\">EGPA<\/jats:styled-content>\n                      , chronic eosinophilic pneumonia (\n                      <jats:styled-content style=\"fixed-case\">CEP<\/jats:styled-content>\n                      ), or bronchial asthma (\n                      <jats:styled-content style=\"fixed-case\">BA<\/jats:styled-content>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We recruited 86 patients with\n                      <jats:styled-content style=\"fixed-case\">EGPA<\/jats:styled-content>\n                      in three groups (remission, relapse, and onset), 25 patients with\n                      <jats:styled-content style=\"fixed-case\">CEP<\/jats:styled-content>\n                      at active or inactive stages of disease, and 11 patients with\n                      <jats:styled-content style=\"fixed-case\">BA<\/jats:styled-content>\n                      . In patients with\n                      <jats:styled-content style=\"fixed-case\">EGPA<\/jats:styled-content>\n                      ,\n                      <jats:styled-content style=\"fixed-case\">CEP<\/jats:styled-content>\n                      , or\n                      <jats:styled-content style=\"fixed-case\">BA<\/jats:styled-content>\n                      , serum\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u201033,\n                      <jats:styled-content style=\"fixed-case\">sST<\/jats:styled-content>\n                      2, and\n                      <jats:styled-content style=\"fixed-case\">TSLP<\/jats:styled-content>\n                      concentrations were determined using\n                      <jats:styled-content style=\"fixed-case\">ELISA<\/jats:styled-content>\n                      and peripheral blood\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2 counts (as Lin\u20101\n                      <jats:sup>\u2212<\/jats:sup>\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      127\n                      <jats:sup>+<\/jats:sup>\n                      <jats:styled-content style=\"fixed-case\">CRTH<\/jats:styled-content>\n                      2\n                      <jats:sup>+<\/jats:sup>\n                      cells) were determined using flow cytometry.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Peripheral blood eosinophil count or\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2 count, and serum\n                      <jats:styled-content style=\"fixed-case\">sST<\/jats:styled-content>\n                      2 or\n                      <jats:styled-content style=\"fixed-case\">TSLP<\/jats:styled-content>\n                      concentration were higher in patients with\n                      <jats:styled-content style=\"fixed-case\">EGPA<\/jats:styled-content>\n                      at onset than in those with\n                      <jats:styled-content style=\"fixed-case\">EGPA<\/jats:styled-content>\n                      at relapse or remission, or in those with\n                      <jats:styled-content style=\"fixed-case\">BA<\/jats:styled-content>\n                      or\n                      <jats:styled-content style=\"fixed-case\">CEP<\/jats:styled-content>\n                      . Serum\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u201033 concentration was higher in patients with\n                      <jats:styled-content style=\"fixed-case\">EGPA<\/jats:styled-content>\n                      at relapse than in those with\n                      <jats:styled-content style=\"fixed-case\">EGPA<\/jats:styled-content>\n                      at onset or remission, or in those with\n                      <jats:styled-content style=\"fixed-case\">BA<\/jats:styled-content>\n                      or\n                      <jats:styled-content style=\"fixed-case\">CEP<\/jats:styled-content>\n                      . In a logistic regression model,\n                      <jats:styled-content style=\"fixed-case\">EGPA<\/jats:styled-content>\n                      disease activity was correlated with serum\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u201033 concentration and peripheral blood\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2 count, but not daily systemic and inhaled corticosteroid dose or immunosuppressant use. Eosinophil count was correlated with peripheral blood\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2 count and serum\n                      <jats:styled-content style=\"fixed-case\">TSLP<\/jats:styled-content>\n                      concentration, but not serum\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u201033 concentration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Increased peripheral blood\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2 count and serum\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u201033 concentration were associated with disease activity in\n                      <jats:styled-content style=\"fixed-case\">EGPA<\/jats:styled-content>\n                      . Increases in serum\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u201033 concentration may indicate the presence of active vasculitis rather than peripheral or tissue eosinophilia.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/cea.13209","type":"journal-article","created":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T09:39:06Z","timestamp":1529141946000},"page":"1305-1316","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Innate immune response reflects disease activity in eosinophilic granulomatosis with polyangiitis"],"prefix":"10.1111","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9722-4569","authenticated-orcid":false,"given":"Naomi","family":"Tsurikisawa","sequence":"first","affiliation":[{"name":"Department of Allergy Hiratuska City Hospital Hiratsuka Japan"},{"name":"Department of Allergy and Respirology National Hospital Organization Sagamihara National Hospital Sagamihara Japan"},{"name":"Department of Pulmonology Yokohama City University Graduate School of Medicine Yokohama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyako","family":"Oshikata","sequence":"additional","affiliation":[{"name":"Department of Allergy Hiratuska City Hospital Hiratsuka Japan"},{"name":"Department of Allergy and Respirology National Hospital Organization Sagamihara National Hospital Sagamihara Japan"},{"name":"Department of Pulmonology Yokohama City University Graduate School of Medicine Yokohama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Microbiology National Institute of Health Science Kawasaki Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tsuburai","sequence":"additional","affiliation":[{"name":"Department of Allergy and Respirology National Hospital Organization Sagamihara National Hospital Sagamihara Japan"},{"name":"Department of Respirology St. Marianna University School of Medicine Yokohama City Seibu Hospital Yokohama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Pulmonology Yokohama City University Graduate School of Medicine Yokohama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Saito","sequence":"additional","affiliation":[{"name":"Clinical Research Center National Hospital Organization Sagamihara National Hospital Sagamihara Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,7,10]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"277","article-title":"Allergic granulomatosis, allergic angiitis, and periarteritis nodosa","volume":"27","author":"Churg J","year":"1951","journal-title":"Am J Pathol"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199901000-00003"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(21)00479-8"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1183\/09031936.94.07112098","article-title":"Chronic eosinophilic pneumonia (CEP) as a presenting feature of Churg\u2010Strauss syndrome (CSS)","volume":"7","author":"Steinfeld S","year":"1994","journal-title":"Eur Respir J"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880475"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.05.040"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2735"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00713.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003020"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1962"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3349"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08636"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08900"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.12.020"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2131"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.06.024"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2104"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201212-2227OC"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005374"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201302-0295OC"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003331"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-203372"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201309"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113476"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-012-1268-7"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/603750"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-267542"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00303"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12582"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.03.015"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13058"},{"key":"e_1_2_6_33_1","unstructured":"GINA.Global Strategy for Asthma Management and Prevention Global Initiative for Asthma May 2015.http:\/\/www.ginasthma.org\/"},{"key":"e_1_2_6_34_1","first-page":"S1","article-title":"Specific IgE Testing Task Force of the American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma and Immunology. Allergy diagnostic testing: an updated practice parameter","volume":"100","author":"Hamilton RG","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.10.036"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-939516"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.R-07-141"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330806"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.rti.0000155268.00125.de"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1309\/F3FW-J8EB-X913-G1RJ"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0953-6205(02)00136-X"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2016.31.1.179"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.170.2.9456932"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-015-0138-4"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199601000-00003"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318205a4c6"},{"key":"e_1_2_6_47_1","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani RA","year":"1994","journal-title":"Q J Med"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gat094"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-536888"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2015.09.016"},{"key":"e_1_2_6_51_1","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood.V86.4.1408.bloodjournal8641408","article-title":"Direct demonstration of cytokine synthesis heterogeneity among human memory\/effector T\u00a0cells by flow cytometry","volume":"86","author":"Picker LJ","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110981"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-014-0032-5"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-013-9898-x"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201531"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161436"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21250"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37721"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.03.003"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-9-200511010-00006"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22686"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.01.016"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.11.037"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.05.037"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcea.13209","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cea.13209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T14:19:52Z","timestamp":1694787592000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cea.13209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,10]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1111\/cea.13209"],"URL":"https:\/\/doi.org\/10.1111\/cea.13209","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,10]]},"assertion":[{"value":"2017-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}